ClinicalTrials.gov
public full text
Public Domain
Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans
The aim is to further establish a physiological role for GLP-1 as an endogenous satiety signal by examining the effect of the specific GLP-1 receptor antagonist exendin (9-39) on appetite and food intake in healthy male subjects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of GLP-1 on Postprandial Lipid Metabolism#1211580
- The Quiet Window–Challenge Window Framework: A Conceptual Framework for Habit Formation During GLP-1 Receptor Agonist Therapy#976849
- The Quiet Window–Challenge Window Framework: A Conceptual Framework for Habit Formation During GLP-1 Receptor Agonist Therapy#976676
- Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years#429684
- Carbohydrates and Gut Hormones After Gastric Bypass Surgery#908400
Record · ID 1336737
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive